Publication | Closed Access

Identification of a novel GLUT1 inhibitor with in vitro and in vivo anti-tumor activity

Tumor BiologyOncologyOncogenic AgentMedicineImmune Checkpoint InhibitorVivo Anti-tumor ActivityAnti-cancer AgentCancer TreatmentNovel Glut1 InhibitorPharmacologyRadiation OncologyCancer Research